Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy.
| Autor: | Witta SE, Jotte RM, Konduri K, Neubauer MA, Spira AI, Ruxer RL, Varella-Garcia M, Bunn PA Jr, Hirsch FR, Witta, Samir E, Jotte, Robert M, Konduri, Katrik, Neubauer, Marcus A, Spira, Alexander I, Ruxer, Robert L, Varella-Garcia, Marileila, Bunn, Paul A Jr, Hirsch, Fred R |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 6/20/2012, Vol. 30 Issue 18, p2248-2255, 8p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|